Core Points - Fortrea sponsors the SCRS Collaborate Forward working group to enhance collaboration and improve clinical trial efficiency [1][2] - The working group consists of 16 leading Global Impact Partner organizations focused on reducing administrative burdens in clinical research [1][2] - The initiative aims to optimize internal processes, promote sustainability in clinical research institutions, and enhance patient experiences [1][2] Company Overview - Fortrea is a leading global provider of clinical development solutions in the life sciences sector, collaborating with biopharmaceutical, biotechnology, medical device, and diagnostic companies [5] - The company offers management services for Phase I to IV clinical trials, clinical pharmacology, and consulting services, leveraging over 30 years of experience across more than 20 therapeutic areas [5] - Fortrea operates in approximately 100 countries with a diverse team, providing targeted and flexible solutions to global clients [5] Industry Context - The clinical trial landscape is becoming increasingly complex, necessitating innovation to ensure patient safety and streamline processes [2] - The Collaborate Forward working group will focus initially on startup research, sharing success stories and data-driven insights to demonstrate the benefits of collaboration [2] - SCRS invites sponsors and CROs committed to sustainable research practices to contribute to a more efficient and collaborative clinical research environment [3]
Society for Clinical Research Sites (SCRS) 联合 Fortrea 共同推进临床研究合作